Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.

@article{Bruyre2007RelationshipBB,
  title={Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate.},
  author={Olivier Bruy{\`e}re and C. Roux and J Detilleux and Daniel O. Slosman and Tim D. Spector and Patrice Fardellone and Kim Brixen and J. P. Devogelaer and Manuel D{\'i}az-Curiel and Carlina Albanese and J. Kaufman and Stig Pors-Nielsen and Jean-Yves Reginster},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2007},
  volume={92 8},
  pages={3076-81}
}
OBJECTIVE Our objective was to analyze the relationship between bone mineral density (BMD) changes and fracture incidence during 3-yr treatment with strontium ranelate. PATIENTS Women from the strontium ranelate arm of the Spinal Osteoporosis Therapeutic Intervention study and the TReatment Of Peripheral OSteoporosis study were evaluated. OUTCOME MEASURES The outcome measures included BMD at the lumbar spine, femoral neck, and total proximal femur assessed at baseline and after a follow-up… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 58 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 45 references

BMD Changes and Fracture Risk with Strontium Ranelate at

  • D Slosman, DM Provvedini, PJ Meunier, PD Delmas, JL Sebert, Ver De
  • J Clin Endocrinol Metab,
  • 2007
2 Excerpts

Similar Papers

Loading similar papers…